PHASE I/II TRIAL OF WEEKLY INTRAVENOUS 130 NM ALBUMIN-BOUND PACLITAXEL AS INITIAL CHEMOTHERAPY IN PATIENTS WITH STAGE IV NON-SMALL-CELL LUNG CANCER

RIZVI, N.A., RIELY, G.J., & AZZOLI, C.G.. (2008). PHASE I/II TRIAL OF WEEKLY INTRAVENOUS 130 NM ALBUMIN-BOUND PACLITAXEL AS INITIAL CHEMOTHERAPY IN PATIENTS WITH STAGE IV NON-SMALL-CELL LUNG CANCER. JOURNAL OF CLINICAL ONCOLOGY, 26(4), 639-643. SID. https://sid.ir/paper/627563/en

RIZVI N.A., RIELY G.J., AZZOLI C.G.. PHASE I/II TRIAL OF WEEKLY INTRAVENOUS 130 NM ALBUMIN-BOUND PACLITAXEL AS INITIAL CHEMOTHERAPY IN PATIENTS WITH STAGE IV NON-SMALL-CELL LUNG CANCER. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 2008;26(4):639-643. Available from: https://sid.ir/paper/627563/en

N.A. RIZVI, G.J. RIELY, and C.G. AZZOLI, “PHASE I/II TRIAL OF WEEKLY INTRAVENOUS 130 NM ALBUMIN-BOUND PACLITAXEL AS INITIAL CHEMOTHERAPY IN PATIENTS WITH STAGE IV NON-SMALL-CELL LUNG CANCER,” JOURNAL OF CLINICAL ONCOLOGY, vol. 26, no. 4, pp. 639–643, 2008, [Online]. Available: https://sid.ir/paper/627563/en